These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 23086545)
21. Association of visual hallucinations with reduction of MIBG cardiac uptake in Parkinson's disease. Kitayama M; Wada-Isoe K; Irizawa Y; Nakashima K J Neurol Sci; 2008 Jan; 264(1-2):22-6. PubMed ID: 17706675 [TBL] [Abstract][Full Text] [Related]
23. Diagnostic Value of the Early Heart-to-Mediastinum Count Ratio in Cardiac 123I-mIBG Imaging for Parkinson's Disease. Frantellizzi V; Lavelli V; Ferrari C; Sardaro A; Farcomeni A; Pacilio M; Borrazzo C; Pani R; Rubini G; Vincentis G Curr Radiopharm; 2021; 14(1):64-69. PubMed ID: 32720610 [TBL] [Abstract][Full Text] [Related]
24. Incremental prognostic value of myocardial neuroadrenergic damage in patients with chronic congestive heart failure: An iodine-123 meta-iodobenzylguanidine scintigraphy study. Giovanni S; Stefano M; Teresa SM; Margherita C; Giovanni B; Umberto P; Paola P; Giacomo C; Pierfranco D; Alfonso G; Riccardo C; Claudio M J Nucl Cardiol; 2020 Oct; 27(5):1787-1797. PubMed ID: 30377997 [TBL] [Abstract][Full Text] [Related]
25. Sensitivity and specificity of cardiac Kawazoe M; Arima H; Maeda T; Tsuji M; Mishima T; Fujioka S; Tsugawa J; Tsuboi Y J Neurol Sci; 2019 Dec; 407():116409. PubMed ID: 31706063 [TBL] [Abstract][Full Text] [Related]
26. [Quantitative analysis of 123I-metaiodobenzylguanidine myocardial imaging: assessment of its usefulness in patients with congestive heart failure]. Narita M; Kurihara T; Murano K; Usami M; Honda M Kaku Igaku; 1994 Apr; 31(4):347-58. PubMed ID: 8196231 [TBL] [Abstract][Full Text] [Related]
27. Importance of renal function on prognostic value of cardiac iodine-123 metaiodobenzylguanidine scintigraphy. Furuhashi T; Moroi M Ann Nucl Med; 2007 Jan; 21(1):57-63. PubMed ID: 17373337 [TBL] [Abstract][Full Text] [Related]
28. Usefulness of Cardiac MetaIodobenzylguanidine Imaging to Improve Prognostic Power of the Model for End-Stage Liver Disease Scoring System in Patients With Mild-to-Moderate Chronic Heart Failure. Hakui H; Yamada T; Tamaki S; Morita T; Furukawa Y; Iwasaki Y; Kawasaki M; Kikuchi A; Kondo T; Ishimi M; Sato Y; Seo M; Ozaki T; Ikeda I; Fukuhara E; Sakata Y; Fukunami M Am J Cardiol; 2016 Jun; 117(12):1947-52. PubMed ID: 27237625 [TBL] [Abstract][Full Text] [Related]
29. Loss of 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value. Satoh A; Serita T; Seto M; Tomita I; Satoh H; Iwanaga K; Takashima H; Tsujihata M J Nucl Med; 1999 Mar; 40(3):371-5. PubMed ID: 10086697 [TBL] [Abstract][Full Text] [Related]
31. A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure. Nakata T; Nakajima K; Yamashina S; Yamada T; Momose M; Kasama S; Matsui T; Matsuo S; Travin MI; Jacobson AF JACC Cardiovasc Imaging; 2013 Jul; 6(7):772-84. PubMed ID: 23845574 [TBL] [Abstract][Full Text] [Related]
32. Cardiac sympathetic denervation and dementia in de novo Parkinson's disease: A 7-year follow-up study. Choi MH; Yoon JH; Yong SW J Neurol Sci; 2017 Oct; 381():291-295. PubMed ID: 28991700 [TBL] [Abstract][Full Text] [Related]
33. Prognostic usefulness of planar Agostini D; Ananthasubramaniam K; Chandna H; Friberg L; Hudnut A; Koren M; Miyamoto MI; Senior R; Shah M; Travin MI; Dahl JV; Chen K; Levy WC; J Nucl Cardiol; 2021 Aug; 28(4):1490-1503. PubMed ID: 31468379 [TBL] [Abstract][Full Text] [Related]
34. Prognostic Significance of Cardiac Seo M; Yamada T; Tamaki S; Watanabe T; Morita T; Furukawa Y; Kawasaki M; Kikuchi A; Kawai T; Nakamura J; Kayama K; Kawahira M; Kimura T; Ueda K; Sakamoto D; Sakata Y; Fukunami M JACC Cardiovasc Imaging; 2022 Apr; 15(4):655-668. PubMed ID: 34656490 [TBL] [Abstract][Full Text] [Related]
35. Cardiac I123-MIBG correlates better than ejection fraction with symptoms severity in systolic heart failure. Miranda SM; Moscavitch SD; Carestiato LR; Felix RM; Rodrigues RC; Messias LR; Azevedo JC; Nóbrega AC; Mesquita ET; Mesquita CT Arq Bras Cardiol; 2013 Jul; 101(1):4-8. PubMed ID: 23917506 [TBL] [Abstract][Full Text] [Related]
36. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease. Suzuki M; Kurita A; Hashimoto M; Fukumitsu N; Abo M; Ito Y; Urashima M; Inoue K J Neurol Sci; 2006 Jan; 240(1-2):15-9. PubMed ID: 16199056 [TBL] [Abstract][Full Text] [Related]
37. Chronological changes of 123I-MIBG myocardial scintigraphy and clinical features of Parkinson's disease. Tsujikawa K; Hasegawa Y; Yokoi S; Yasui K; Nanbu I; Yanagi T; Takahashi A J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):945-51. PubMed ID: 25935888 [TBL] [Abstract][Full Text] [Related]
38. Optimal Protocol and Clinical Usefulness of Chun IK Nucl Med Mol Imaging; 2023 Jun; 57(3):145-154. PubMed ID: 37187951 [TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of cardiac I-123-metaiodobenzylguanidine imaging in patients with reduced, mid-range, and preserved left ventricular ejection fraction admitted for acute decompensated heart failure: a prospective study in Osaka Prefectural Acute Heart Failure Registry (OPAR). Seo M; Yamada T; Tamaki S; Watanabe T; Morita T; Furukawa Y; Kawasaki M; Kikuchi A; Kawai T; Abe M; Nakamura J; Yamamoto K; Kayama K; Kawahira M; Tanabe K; Kimura T; Ueda K; Sakamoto D; Sakata Y; Fukunami M Eur Heart J Cardiovasc Imaging; 2021 Jan; 22(1):58-66. PubMed ID: 32091079 [TBL] [Abstract][Full Text] [Related]
40. Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death. Wakabayashi T; Nakata T; Hashimoto A; Yuda S; Tsuchihashi K; Travin MI; Shimamoto K J Nucl Med; 2001 Dec; 42(12):1757-67. PubMed ID: 11752070 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]